Point72 Hong Kong Ltd Invests $2.96 Million in Axon Enterprise, Inc. (NASDAQ:AXON)

Point72 Hong Kong Ltd bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the third quarter, according to its most recent filing with the SEC. The firm bought 7,404 shares of the biotechnology company’s stock, valued at approximately $2,959,000.

Several other institutional investors have also recently bought and sold shares of AXON. CIBC Asset Management Inc lifted its holdings in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after buying an additional 895 shares during the last quarter. Foundations Investment Advisors LLC acquired a new stake in Axon Enterprise in the 3rd quarter worth $221,000. Sequoia Financial Advisors LLC increased its holdings in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after purchasing an additional 81 shares during the period. Axxcess Wealth Management LLC acquired a new position in shares of Axon Enterprise during the third quarter valued at about $814,000. Finally, Soros Capital Management LLC bought a new stake in shares of Axon Enterprise in the third quarter valued at about $630,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 1.9 %

NASDAQ AXON opened at $646.96 on Monday. The stock’s 50 day simple moving average is $488.25 and its 200 day simple moving average is $379.59. Axon Enterprise, Inc. has a one year low of $224.28 and a one year high of $652.22. The firm has a market cap of $49.33 billion, a PE ratio of 167.17, a price-to-earnings-growth ratio of 14.24 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 25,811 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now owns 228,166 shares in the company, valued at $82,103,253.44. The trade was a 10.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 210,256 shares of company stock valued at $87,783,120. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on AXON. Craig Hallum boosted their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Robert W. Baird upped their target price on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Finally, JMP Securities upped their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.